Dr. Georgios Kollias M.D.

Werner Rainer, CEO of XSpline comments on the first patient enrolling in the International Clinical Trial for the company’s Non-Invasive Cardiac Resynchronization Therapy

(IN BRIEF) I am excited to share that XSpline SPA and Ordensklinikum Linz Elisabethinen Hospital have enrolled the first patient…

1 year ago

Dr. Georgios Kollias, M.D., comments on the enrollment of the first patient in the Clinical Study for Cardiac Resynchronization Therapy Using XSpline Cloud’s Non-Invasive Technology

(IN BRIEF) Dr. Georgios Kollias, the principal investigator for the clinical trial in Austria, expressed great satisfaction with the XSpline…

1 year ago

XSpline SPA / University of Linz (Austria): the first patient has been enrolled in the international multicenter clinical study for the Cardiac Resynchronization Therapy DeliveRy guided by non-Invasive electrical and VEnous anatomy assessment (CRT-DRIVE)

XSpline Cloud: First-in-class cloud platform for personalized cardiac resynchronization therapy evaluated in International Clinical Trial; first procedure performed at the…

1 year ago